TY - JOUR
T1 - Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy
AU - Du, Yuxin
AU - Wu, Lin
AU - Wang, Litao
AU - Reiter, Russel J.
AU - Lip, Gregory Y. H.
AU - Ren, Jun
N1 - Copyright © 2023 Elsevier Ltd. All rights reserved.
PY - 2023/12
Y1 - 2023/12
N2 - Extracellular vesicles (EVs), encompassing exosomes, microvesicles (MVs), and apoptotic bodies (ABs), are cell-derived heterogeneous nanoparticles with a pivotal role in intercellular communication. EVs are enclosed by a lipid-bilayer membrane to escape enzymatic degradation. EVs contain various functional molecules (e.g., nucleic acids, proteins, lipids and metabolites) which can be transferred from donor cells to recipient cells. EVs provide many advantages including accessibility, modifiability and easy storage, stability, biocompatibility, heterogeneity and they readily penetrate through biological barriers, making EVs ideal and promising candidates for diagnosis/prognosis biomarkers and therapeutic tools. Recently, EVs were implicated in both physiological and pathophysiological settings of cardiovascular system through regulation of cell-cell communication. Numerous studies have reported a role for EVs in the pathophysiological progression of cardiovascular diseases (CVDs) and have evaluated the utility of EVs for the diagnosis/prognosis and therapeutics of CVDs. In this review, we summarize the biology of EVs, evaluate the perceived biological function of EVs in different CVDs along with a consideration of recent progress for the application of EVs in diagnosis/prognosis and therapies of CVDs.
AB - Extracellular vesicles (EVs), encompassing exosomes, microvesicles (MVs), and apoptotic bodies (ABs), are cell-derived heterogeneous nanoparticles with a pivotal role in intercellular communication. EVs are enclosed by a lipid-bilayer membrane to escape enzymatic degradation. EVs contain various functional molecules (e.g., nucleic acids, proteins, lipids and metabolites) which can be transferred from donor cells to recipient cells. EVs provide many advantages including accessibility, modifiability and easy storage, stability, biocompatibility, heterogeneity and they readily penetrate through biological barriers, making EVs ideal and promising candidates for diagnosis/prognosis biomarkers and therapeutic tools. Recently, EVs were implicated in both physiological and pathophysiological settings of cardiovascular system through regulation of cell-cell communication. Numerous studies have reported a role for EVs in the pathophysiological progression of cardiovascular diseases (CVDs) and have evaluated the utility of EVs for the diagnosis/prognosis and therapeutics of CVDs. In this review, we summarize the biology of EVs, evaluate the perceived biological function of EVs in different CVDs along with a consideration of recent progress for the application of EVs in diagnosis/prognosis and therapies of CVDs.
KW - Cardiovascular diseases
KW - Diagnosis
KW - Extracellular vesicles
KW - Pathophysiology
KW - Prognosis
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=85173163008&partnerID=8YFLogxK
U2 - 10.1016/j.cytogfr.2023.09.006
DO - 10.1016/j.cytogfr.2023.09.006
M3 - Review article
C2 - 37798169
SN - 1359-6101
VL - 74
SP - 40
EP - 55
JO - Cytokine & Growth Factor Reviews
JF - Cytokine & Growth Factor Reviews
ER -